𝔖 Bobbio Scriptorium

✦ LIBER ✦

Famotidine, a histamine H2-receptor antagonist, and negative symptoms of schizophrenia : Rami Kaminski M.D., Thomas Moriarty, Ph.D., Dennis Wolf, M.D., Deborah Culliton, M.A., John Bodine, M.D., Michael Davidson, M.D., Kenneth L. Davis, M.D. Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029.

Book ID: 118855247
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 243 KB
Volume: 29
Category: Article
ISSN: 0006-3223
DOI: 10.1016/0006-3223(91)91020-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuropsychological performance of neurol

Neuropsychological performance of neuroleptic nonresponsive schizophrenic patients : Philip D. Harvey, Ph.D., Jack Blanchard, M.A., Michael Davidson, M.D., Robert Stern, M.D., John M. Neale, Ph.D. Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Postdexamethasone cortisol predicts agit

Postdexamethasone cortisol predicts agitation but not rate of progression in Alzheimer's disease : Brian A. Lawlor, M.D., Peter Aupperle, M.D., Richard C. Mohs, Ph.D., Gabriel Tsubuyama, M.D., Bonnie M. Davis, M.D., Michael Davidson, M.D., and Kenneth L. Davis, M.D. Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Event related potentials in schizotypal

Event related potentials in schizotypal personality disorder and schizophrenia : Oren Kalus, M.D., Thomas B. Horvath, M.D.. Ann Peterson, M.A., Emil F. Coccaro, M.D., Vivian Mitropoulou, M.A., Michael Davidson, M.D., Kenneth L. Davis, M.D., Larry J. Siever, M.D. Mount Sinai School of Medicine and Veterans Affairs Medical Center, New York, NY 10029

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Dementia in elderly schizophrenic patien

Dementia in elderly schizophrenic patients clinical and neuropathological correlates : Michael Davidson, M.D., Peter Powchik, M.D., Miklos F. Losonczy, M.D., Ph.D., Shlomit Katz, M.D., Janice McCrystal, R.N., Michael Parella, Ph.D., Ede Frecska, M.D., Vahram Haroutunian, Ph.D., Linda Bierer, M.D., Daniel Perl, M.D., Marvin Goldstein, Ph.D., Kenneth L. Davis, M.D. Mount Sinai School of Medicine/Pilgrim Psychiatric Center, Department of Psychiatry, New York, NY 10029

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Neuroleptic-discontinuation variables as

Neuroleptic-discontinuation variables as predictors of treatment response in chronic schizophrenic patients : Katherine M. Putman, M.A. (by invitation), Philip D. Harvey, Ph.D., Michael Davidson, M.D., Grant Ko, M.D., Kenneth L. Davis, M.D. Bronx Veterans Affairs Medical Center and Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Altered relationship of plasma FFA and D

Altered relationship of plasma FFA and DBH activity in schizophrenia : Nancy Wolfe, M.D., Peter J. Knott, Ph.D., Michael Davidson, M.D., Neill Runyon, B.A., and Kenneth L. Davis, M.D. Departments of Psychiatry (all authors) and Pharmacology (P.K., K.L.D.), The Mount Sinai School of Medicine, New York, NY 10029

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 214 KB